ORs of adverse pregnancy outcomes by different glycemic markers
| Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | P for trend | As continuous variables | |
| FPG | ||||||
| No of patients | 502 | 494 | 494 | 486 | ||
| No of cases | 182 | 194 | 217 | 296 | ||
| Model 1 | 1.00 | 1.13 (0.88–1.46) | 1.37 (1.06–1.77) | 2.70 (2.89–3.50) | <0.001 | 2.40 (1.96–3.95) |
| Model 2 | 1.00 | 1.19 (0.92–1.55) | 1.40 (1.08–1.81) | 2.57 (1.95–3.38) | <0.001 | 2.32 (1.85–2.92) |
| 1hPG | ||||||
| No of patients | 495 | 497 | 491 | 493 | ||
| No of cases | 191 | 218 | 231 | 249 | ||
| Model 1 | 1.00 | 1.24 (0.96–1.60) | 1.40 (1.09–1.80) | 1.59 (1.23–2.05) | 0.004 | 1.13 (1.07–1.20) |
| Model 2 | 1.00 | 1.23 (0.95–1.59) | 1.28 (0.99–1.67) | 1.12 (0.81–1.55) | 0.235 | 1.07 (1.01–1.15) |
| 2hPG | ||||||
| No of patients | 499 | 494 | 490 | 493 | ||
| No of cases | 203 | 206 | 227 | 253 | ||
| Model 1 | 1.00 | 1.04 (0.81–1.34) | 1.24 (0.96–1.60) | 1.50 (1.17–1.94) | 0.006 | 1.11 (1.05–1.17) |
| Model 2 | 1.00 | 1.01 (0.78–1.30) | 1.17 (0.91–1.52) | 1.05 (0.76–1.45) | 0.591 | 1.03 (0.96–1.10) |
| HbA1c | ||||||
| No of patients | 609 | 517 | 443 | 407 | ||
| No of cases | 248 | 216 | 192 | 233 | ||
| Model 1 | 1.00 | 1.04 (0.82–1.32) | 1.10 (0.86–1.41) | 1.91 (1.48–2.47) | <0.001 | 1.99 (1.53–2.59) |
| Model 2 | 1.00 | 1.03 (0.81–1.32) | 1.07 (0.83–1.38) | 1.72 (1.31–2.24) | <0.001 | 1.77 (1.34–2.33) |
| 1,5-AG | ||||||
| No of patients | 518 | 486 | 499 | 473 | ||
| No of cases | 284 | 213 | 205 | 187 | ||
| Model 1 | 1.00 | 0.65 (0.51–0.84) | 0.58 (0.45–0.74) | 0.55 (0.42–0.70) | <0.001 | 0.95 (0.93–0.97) |
| Model 2 | 1.00 | 0.67 (0.52–0.86) | 0.63 (0.49–0.81) | 0.62 (0.47–0.81) | <0.001 | 0.96 (0.94–0.98) |
Model 1 adjusted for age.
Model 2 adjusted for age, body mass index, family history of diabetes, gestational complications, gestational age at oral glucose tolerance test, infant’s sex, and parities.
FPG, fasting plasma glucose.